Omalizumab Subcutaneous and Orthoclone OKT 3
Determining the interaction of Omalizumab Subcutaneous and Orthoclone OKT 3 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: muromonab-cd3
Brand name:
Synonyms: Orthoclone OKT 3 (Intravenous), Orthoclone OKT3
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Orthovisc
- Omalizumab Subcutaneous-Orudis
- Omalizumab Subcutaneous-Orudis KT
- Omalizumab Subcutaneous-Oruvail
- Omalizumab Subcutaneous-Orvaten
- Omalizumab Subcutaneous-Os-Cal 500+D
- Orthoclone OKT 3-Ombitasvir, Paritaprevir, and Ritonavir
- Orthoclone OKT 3-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Orthoclone OKT 3-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Orthoclone OKT 3-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Orthoclone OKT 3-Omeclamox-Pak
- Orthoclone OKT 3-Omega-3 Fatty Acid Capsules